Category: Finance | Title: What Can I Take to Lose Belly Fat According to Latest Data | Tag: belly fat | Meta Description: Evidence-based options for belly fat reduction, including prescription drugs, supplements, and lifestyle strategies supported by recent studies and market data...
Prescription and FDA-Approved Options for Belly Fat Reduction
GLP-1 receptor agonists such as semaglutide and tirzepatide are among the most clinically effective pharmacotherapies for reducing visceral belly fat. Semaglutide, sold under the brand name Wegovy for weight management, received FDA approval in June 2021 for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity. Tirzepatide, marketed as Mounjaro, was first approved by the FDA in May 2022 for type 2 diabetes and later for weight management, showing average body weight reductions of up to 20.9% in clinical trials. These medications work by mimicking incretin hormones that regulate appetite and gastric emptying. Costs vary widely, with monthly list prices often exceeding $1,000 in the U.S., though manufacturer savings cards and insurance coverage can lower out-of-pocket expenses. For those considering these options, consulting a healthcare provider is essential to evaluate eligibility, potential side effects, and suitability based on individual health profiles FDA drug approval database.
Beyond GLP-1 agonists, other FDA-approved medications can indirectly support belly fat loss when combined with diet and exercise. Orlistat, available both by prescription as Xenical and over-the-counter as Alli, works by inhibiting pancreatic lipase to reduce dietary fat absorption by approximately 30%. Phentermine-topiramate, sold as Qsymia, combines an appetite suppressant with a mood-stabilizing anticonvulsant and has demonstrated average weight loss of 10% or more in clinical studies. Liraglutide, marketed as Saxenda, is another daily injectable option approved in 2014 for weight management. These medications are typically indicated for adults with a BMI of 30 or higher, or 27 or higher with weight-related conditions such as hypertension or type 2 diabetes. Market demand for these pharmaceuticals has driven significant revenue growth for manufacturers Novo Nordisk and Eli Lilly, with GLP-1 receptor agonist sales reaching tens of billions of dollars globally Forbes industry analysis.
Supplements and Natural Compounds with Evidence for Belly Fat
Several dietary supplements have shown modest effects on belly fat in clinical studies, though results vary and supplement regulation differs from prescription drugs. Soluble fiber supplements such as glucomannan, derived from the konjac root, can promote satiety and contribute to modest weight loss when taken before meals. A meta-analysis published in the Journal of Obesity found that glucomannan supplementation led to an average weight loss of 1.3 kg compared to placebo over several weeks. Green tea extract, standardized for catechins and caffeine, has been associated with small but significant reductions in body weight and waist circumference in randomized controlled trials. Conjugated linoleic acid, a naturally occurring fatty acid found in meat and dairy, has shown a small reduction in body fat mass in some studies, though effects on belly fat specifically remain inconsistent. Probiotics, particularly strains of Lactobacillus gasseri, have demonstrated reductions in abdominal visceral fat in several human trials, suggesting a link between gut microbiome composition and fat storage patterns PubMed clinical review.
Other supplements marketed for belly fat reduction include apple cider vinegar, medium-chain triglyceride oil, and caffeine-based thermogenics. Apple cider vinegar, typically consumed in diluted form, has been linked to small reductions in body weight and waist circumference in limited human studies, though evidence remains preliminary and effects are modest. M